Rare diseases
Investigational molecules
Locations
Study of fludarabine phosphate in patients with blood cancer undergoing lymphodepletion before CAR-T cell therapy
BelgiumStudy on Extracellular Vesicles in Hematology Patients Treated with Brexucabtagene Autoleucel and Drug Combination
FranceLong-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel
AustriaStudy on Golcadomide for Patients with Relapsed or Refractory Aggressive Large B-Cell Lymphoma at High Risk of Relapse After CAR T-Cell Therapy
FranceStudy of Tisagenlecleucel for Treating Adult Patients with Resistant or Relapsed B-cell Acute Lymphoblastic Leukemia
PolandStudy on Nivolumab and Tisagenlecleucel for Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia After Treatment Loss
FranceStudy on the Effectiveness and Safety of Tisagenlecleucel for Adults with Hard-to-Treat or Returning Follicular Lymphoma
BelgiumStudy on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease
BelgiumStudy of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
AustriaStudy Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
